ipamorelin human study CJC-1295 & Blend (10mg) ipamorelin clinical trials human studies
Description
Off-label peptides like CJC-1295/ipamorelin and AOD-9604 have shorter track records but are generally well-tolerated when administered under medical supervision
Gonzlez-Alcaide G, Llorente P, Ramos-Rincn JM
Primary Care 44: 673692
Modern treatment is targeted toward lowering IOP, but this only slows progression and often still leads to blindness
Science 382:eadf7044
doi: 10.1176/ajp.154.3.426
